MENTAL MOTION PRO es un producto ADNe® Systems de JCBSON Analytics
Powered by JCBSON Analytics
A pilot trial conducted in Valencia in collaboration with the BIONOS Biotech laboratory has demonstrated that 29 questions and less than 5 minutes are enough to estimate plasma biomarkers with unprecedented reliability in psychometrics.
In 2018, JCBSON received the AEDEM award for research on early warning signs in Alzheimer's Disease. Years later, in February 2026, JCBSON and BIONOS Biotech (LabAnalysis Group) conducted a comparative study: the same volunteers, on the same day, completed the ADNe® test and underwent a real blood draw to measure cortisol, IL-6, and testosterone in the laboratory.
The most widely used personality tests (Big Five, DISC, MBTI) hover between 0% and 5% biological accuracy, while the best clinical psychological instrument reaches 18%. ADNe® doesn't just improve on that slightly (86%): it multiplies it by three to eight times.
The correlation between the ADNe® test results and plasma biomarkers was independently verified by the BIONOS Biotech laboratory.
A reference laboratory specialized in plasma biomarkers. Validation was performed via real blood draws and independent analysis, with no JCBSON intervention during the laboratory phase.
The protocol compared the ADNe® test results with real measurements of cortisol, IL-6, and testosterone obtained on the same day from the same volunteers.
ADNe® does not replace clinical diagnosis. It is the first layer of screening that currently does not exist in any corporate or clinical environment.
Ongoing research regarding the early detection of behavioral patterns associated with Alzheimer's and Parkinson's before the onset of overt motor or cognitive symptoms.
The neurochemical profile estimated by ADNe® identifies synaptic patterns associated with OCD, generalized anxiety, and social phobia with unprecedented screening accuracy.
Detection of the biological load of stress before it becomes visible. The difference between acting in time or managing long-term sick leave.
IL-6 can remain elevated for months without symptoms. ADNe® identifies who should get a real blood test before any clinical signs appear.
Objective assessment of the biological status of entire teams. Compliance with Labor Risk Prevention laws using hard data where there used to be only intuition.
An estimated neurochemical profile before the first session. The professional arrives with objective data, rather than relying solely on what the patient remembers or chooses to share.
Important Note: The ADNe® test and Mental Motion Pro are tools for screening and neurobehavioral estimation, not for clinical diagnosis. The results do not replace a blood test, a doctor's assessment, or a diagnosis by a mental health professional. Their purpose is to identify warning signs that warrant a deeper clinical evaluation. The pilot trial data corresponds to a preliminary validation study conducted in February 2026.
Request your free demo and see within 7 days how MMP changes the way you understand the people under your care.
✦ Request a free demoMENTAL MOTION PRO es un producto ADNe® Systems de JCBSON Analytics
Powered by JCBSON Analytics